|
|
|
viii | |
| The beginnings of human in vitro fertilization |
|
xii | |
|
|
| Robert Edwards: The path to IVF |
|
xxv | |
|
|
|
IX Quality Management Systems |
|
|
|
32 Quality management in reproductive medicine |
|
|
1 | (9) |
|
|
|
|
|
|
|
|
|
|
|
X Patient Investigation and the Use of Drugs |
|
|
|
33 Lifestyle, periconception, and fertility |
|
|
10 | (8) |
|
|
|
|
|
|
|
34 Indications for IVF treatment: From diagnosis to prognosis |
|
|
18 | (13) |
|
|
|
|
|
|
|
|
|
|
|
|
|
35 Initial investigation of the infertile couple |
|
|
31 | (10) |
|
|
|
|
|
|
|
|
|
36 Prognostic testing for ovarian reserve |
|
|
41 | (10) |
|
|
|
|
|
|
|
|
|
37 Drugs used for ovarian stimulation: Clomiphene citrate, aromatase inhibitors, metformin, gonadotropins, gonadotropin-releasing hormone analogs, and recombinant gonadotropins |
|
|
51 | (24) |
|
|
|
|
|
38 The role of FSH and LH in ovulation induction: Current concepts |
|
|
75 | (24) |
|
|
|
|
|
|
39 Endocrine characteristics of ART cycles |
|
|
99 | (16) |
|
|
|
|
|
40 The use of GnRH agonists |
|
|
115 | (9) |
|
|
|
|
|
41 GnRH-antagonists in ovarian stimulation for IVF |
|
|
124 | (7) |
|
Efstratios M. Kolibianakis |
|
|
|
|
|
|
42 The use of AMH to tailor ovarian stimulation for IVF |
|
|
131 | (9) |
|
|
|
43 Monitoring ovarian response in IVF cycles |
|
|
140 | (5) |
|
|
|
|
|
|
|
145 | (8) |
|
|
|
|
|
153 | (9) |
|
|
|
|
|
|
|
|
|
|
|
|
|
46 Treatment strategies in assisted reproduction for the poor responder patient |
|
|
162 | (46) |
|
|
|
|
|
47 Repeated implantation failure |
|
|
208 | (17) |
|
|
|
|
|
XII Technical Procedures and Outcomes |
|
|
|
48 Ultrasonography in assisted reproduction |
|
|
225 | (17) |
|
|
|
|
|
49 Sperm recovery techniques: Clinical aspects |
|
|
242 | (16) |
|
|
|
|
|
50 Processing and cryopreservation of testicular sperm |
|
|
258 | (5) |
|
|
|
|
|
|
|
|
|
51 Embryo transfer technique |
|
|
263 | (9) |
|
|
|
52 Cycle regimes for frozen-thawed embryo transfer |
|
|
272 | (6) |
|
|
|
|
|
53 Anesthesia and in vitro fertilization |
|
|
278 | (6) |
|
|
|
|
|
54 Medical considerations of single embryo transfer |
|
|
284 | (4) |
|
|
|
XIII Special Medical Conditions |
|
|
|
|
|
288 | (10) |
|
|
|
|
|
|
|
56 PCOS and assisted reproduction |
|
|
298 | (10) |
|
|
|
|
|
|
|
|
|
57 Management of hydrosalpinx |
|
|
308 | (10) |
|
|
|
58 Fertility preservation strategies |
|
|
318 | (15) |
|
|
|
|
|
|
|
59 Viral disease and Assisted Reproductive Techniques |
|
|
333 | (8) |
|
|
|
XIV Complications of Treatment |
|
|
|
60 Severe ovarian hyperstimulation syndrome |
|
|
341 | (19) |
|
|
|
|
|
|
|
61 The environment and reproduction |
|
|
360 | (14) |
|
|
|
62 Bleeding, severe pelvic infection, and ectopic pregnancy |
|
|
374 | (8) |
|
|
|
|
|
63 Iatrogenic multiple pregnancies: The risk of ART |
|
|
382 | (12) |
|
|
|
XV Egg Donation and Surrogate Motherhood |
|
|
|
64 Egg and embryo donation |
|
|
394 | (11) |
|
|
|
|
|
|
|
405 | (10) |
|
|
|
|
|
|
66 The evolving role of the ART nurse: A contemporary review |
|
|
415 | (9) |
|
|
|
67 Patient support in the ART program |
|
|
424 | (10) |
|
|
|
68 The relationship between stress and in vitro fertilization outcome |
|
|
434 | (7) |
|
Andrea Mechanick Braverman |
|
|
XVII Ethics, Religion and Legislation |
|
|
|
69 The impact of legislation and socioeconomic factors in the access to and global practice of assisted reproduction |
|
|
441 | (10) |
|
Fernando Zegers-Hochschild |
|
|
|
|
|
|
70 Religious perspectives in human reproduction |
|
|
451 | (6) |
|
|
|
|
| Index |
|
457 | |
